Sign In to Follow Application
View All Documents & Correspondence

Method For Producing Nanoparticles Including Metal Particles Containing Iron Oxide Having At Least One Hydrophilic Ligand Coordinated Thereto

Abstract: [Problem] To provide a novel method for producing nanoparticles which include metal particles containing iron oxide having at least one hydrophilic ligand coordinated thereto, and are useful as a contrast agent for magnetic resonance imaging. [Solution] The present invention provides a novel method for producing nanoparticles which include metal particles containing iron oxide having at least one hydrophilic ligand coordinated thereto, wherein ligand exchange for a hydrophilic ligand from iron oxide nanoparticles having a hydrophobic ligand coordinated to the surface thereof is carried out in a single process by using a phase-transfer catalyst, and it is thus expected that the production steps and the amount of hydrophilic ligand used will be reduced. In addition, the iron oxide nanoparticles having a hydrophobic ligand coordinated to the surface thereof are produced using a dropping method, thereby making it possible to avoid a rapid temperature increase or a reaction at a high temperature of 200°C or higher. The present invention is thus more advantageous for industrial production.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
25 June 2021
Publication Number
27/2021
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
patent@depenning.com
Parent Application

Applicants

ASTELLAS PHARMA INC.
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411

Inventors

1. KIKUCHI, Takashi
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411
2. MIZUTANI, Tsuyoshi
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411
3. TOYA, Hiroki
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411
4. KURODA, Akio
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411
5. GOTO, Yota
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411
6. HIRASAWA, Shun
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411
7. SUGIMORI, Toshiyuki
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411

Specification

Documents

Application Documents

# Name Date
1 202147028560-STATEMENT OF UNDERTAKING (FORM 3) [25-06-2021(online)].pdf 2021-06-25
2 202147028560-PRIORITY DOCUMENTS [25-06-2021(online)].pdf 2021-06-25
3 202147028560-POWER OF AUTHORITY [25-06-2021(online)].pdf 2021-06-25
4 202147028560-FORM 1 [25-06-2021(online)].pdf 2021-06-25
5 202147028560-DRAWINGS [25-06-2021(online)].pdf 2021-06-25
6 202147028560-DECLARATION OF INVENTORSHIP (FORM 5) [25-06-2021(online)].pdf 2021-06-25
7 202147028560-COMPLETE SPECIFICATION [25-06-2021(online)].pdf 2021-06-25
8 202147028560-Proof of Right [18-10-2021(online)].pdf 2021-10-18
9 202147028560.pdf 2021-10-19
10 202147028560-Correspondence_Form1(Proof of Right)_27-10-2021.pdf 2021-10-27
11 202147028560-FORM 3 [10-12-2021(online)].pdf 2021-12-10
12 202147028560-FORM 18 [30-11-2022(online)].pdf 2022-11-30
13 202147028560-FER.pdf 2023-01-16
14 202147028560-AbandonedLetter.pdf 2023-12-27

Search Strategy

1 SearchHistoryE_11-01-2023.pdf